Drug-induced lymphopenia - Focus on CD4+and CD8+cells

被引:33
作者
Gergely, P [1 ]
机构
[1] Semmelweis Univ Med, Cent Lab Immunol, H-1085 Budapest, Hungary
关键词
D O I
10.2165/00002018-199921020-00003
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Drug-induced lymphopenia is a common adverse event. Some drugs, in particular those used in the treatment of malignancies and autoimmune diseases, inevitably affect the percentages and proportions of lymphocytes in the peripheral blood. Some other drugs exert only minor effects and their clinical relevance cannot be established with certainty. Most cytotoxic and immunosuppressive drugs affect CD4+ T cells more profoundly. Since their regeneration seems to be slower than that of CD8+ T cells, the frequent occurrence of CD4+ lymphopenia may merely reflect this phenomenon. As in HIV infection, critically low numbers of CD4+ cells, irrespective of the cause, predisposes to opportunistic infections. There is no such critically low value for CD8+ cells, and their essential role in various pathological conditions should also be established.
引用
收藏
页码:91 / 100
页数:10
相关论文
共 77 条
[1]   Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years [J].
Adami, S ;
Bufalino, L ;
Cervetti, R ;
DiMarco, C ;
DiMunno, O ;
Fantasia, L ;
Isaia, GC ;
Serni, U ;
Vecchiet, L ;
Passeri, M ;
Castiglione, GN ;
Gardini, F ;
Letizia, G ;
Occhipinti, L ;
Pardini, N ;
Agamennone, M ;
Sciolla, A ;
Matucci, A ;
Riboldi, R ;
Costi, D ;
DallAglio, E ;
Pedrazzoni, M .
OSTEOPOROSIS INTERNATIONAL, 1997, 7 (02) :119-125
[2]   Efficacy of ipriflavone in established osteoporosis and long-term safety [J].
Agnusdei, D ;
Bufalino, L .
CALCIFIED TISSUE INTERNATIONAL, 1997, 61 (Suppl 1) :S23-S27
[3]   M-kansasii pulmonary disease in idiopathic CD4+ T-lymphocytopenia [J].
Anzalone, G ;
Cei, M ;
Vizzaccaro, A ;
Tramma, B ;
Bisetti, A .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (08) :1754-1756
[4]   ACUTE EFFECTS OF SINGLE DOSES OF RECOMBINANT INTERFERON-GAMMA ON BLOOD-CELL COUNTS AND LYMPHOCYTE SUBSETS IN PATIENTS WITH ADVANCED RENAL-CELL CANCER [J].
AULITZKY, WE ;
AULITZKY, W ;
GASTL, G ;
LANSKE, B ;
REITTER, J ;
FRICK, J ;
TILG, H ;
BERGER, M ;
HEROLD, M ;
HUBER, C .
JOURNAL OF INTERFERON RESEARCH, 1989, 9 (04) :425-433
[5]   Fulminant Pneumocystis carinii pneumonia in 4 patients with dermatomyositis [J].
Bachelez, H ;
Schremmer, B ;
Cadranel, J ;
Mouly, F ;
Sarfati, C ;
Agbalika, F ;
Schlemmer, B ;
Mayaud, CM ;
Dubertret, L .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (13) :1501-1503
[6]   CONTRASTING EFFECTS OF CYCLOPHOSPHAMIDE AND PREDNISOLONE ON THE PHENOTYPE OF HUMAN PERIPHERAL-BLOOD LEUKOCYTES [J].
BAST, RC ;
REINHERZ, EL ;
MAVER, C ;
LAVIN, P ;
SCHLOSSMAN, SF .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1983, 28 (01) :101-114
[7]  
BAUER R, 1989, J INVEST DERMATOL, V93, P540
[8]  
BEUTLER E, 1994, ACTA HAEMATOL-BASEL, V91, P10
[9]   Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia [J].
Blay, JY ;
Chauvin, F ;
LeCesne, A ;
Anglaret, B ;
Bouhour, D ;
Lasset, C ;
Freyer, G ;
Philip, T ;
Biron, P .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) :636-643
[10]  
BOFILL M, 1992, CLIN EXP IMMUNOL, V88, P243, DOI 10.1111/j.1365-2249.1992.tb03068.x